The note is the current scenario (Base). Download PDF renders this page on the server, fonts and colours exact; Print uses the browser.
Model Note · ROSSARI BIOTECH LIMITED · 11 September 2026Page 1 of 2
Model Note
Prepared by the reader · not a MarketPing document
ROSSARI BIOTECH LIMITED Discounted cash flow · base FY26
ROSSARI BIOTECH LIMITED
Value per share, this model₹105
CMP 2026-09-10₹448.00
Difference(76.6)%
Growth the CMP implies45.0%/yr
This note states the assumptions and the arithmetic of one model of ROSSARI BIOTECH LIMITED, built on its filed FY26 consolidated statements. The value is the outcome of the assumptions below and nothing else; it is not a fair value, a target or a recommendation.
Assumptions
Input
This model
Filed reference
Revenue growth, 5 years
15% a year
FY26 15.2% · 5-yr CAGR 27.6%
EBITDA margin
11.9%
FY26 11.9% · 5-yr average 12.8%
Depreciation · capex, % of revenue
3.3% · 11%, fading to 1.2× depreciation
FY26 3.3% · 11.0%
Working capital, % of added revenue · tax
26.7% · 26.6%
97 working-capital days · effective 26.6%
Discount rate
11.00%
1-yr beta 1.19
After FY31
5% flat · mid-year discounting
—
Net debt · non-controlling interest · non-operating investments
₹333 · ₹0 · ₹0 cr
FY26 net debt ₹333 cr
Shares
5.54 crore
5.54 crore today
Source: SEBI results XBRL as filed with BSE/NSE, exchange prices; the reader's assumptions.
Projected cash flow to the firm
₹ crore
FY26
FY27
FY28
FY29
FY30
FY31
Revenue
2,396
2,756
3,169
3,645
4,191
4,820
growth %
15.2
15.0
15.0
15.0
15.0
15.0
EBITDA
286
328
377
434
499
574
Depreciation
(79)
(91)
(105)
(120)
(138)
(159)
NOPAT
152
174
200
230
265
304
less capex
(265)
(303)
(293)
(273)
(240)
(191)
less working-capital build
—
(96)
(110)
(127)
(146)
(168)
Free cash flow to firm
—
(134)
(99)
(49)
17
105
Present value
(127)
(84)
(38)
12
65
Source: the model; base year as filed.
Every figure is the reader's model over filed numbers · No rating, target or fair value is expressedmarketping.in
Model Note · ROSSARI BIOTECH LIMITED · 11 September 2026Page 2 of 2
From enterprise to equity
PV of the 5 explicit years
(172)
PV of the terminal value (119% of EV)
1,086
Enterprise value
914
less net debt
(333)
less non-controlling interest
0
add non-operating investments
0
Equity value
581
÷ 5.54 crore shares
₹105
Source: the model.
Sensitivity, ₹ per share
WACC ↓ · terminal growth →
4.0%
4.5%
5.0%
5.5%
6.0%
10.0%
112
132
155
184
220
10.5%
92
108
128
151
179
11.0%
75
89
105
124
146
11.5%
61
72
86
101
120
12.0%
48
58
69
83
98
Source: the model; n/a where terminal growth reaches the discount rate.
Statement
This note is the reader's own model over publicly filed information: SEBI results XBRL filed with BSE and NSE and exchange price data, assembled by MarketPing software; every assumption above is the reader's. It contains no research recommendation, no price target and no opinion by MarketPing on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Historical per-share figures are on the current share count. Where a figure is unavailable the table shows a dash rather than an estimate. Nothing here constitutes investment advice, an offer or a solicitation.
Every figure is the reader's model over filed numbers · No rating, target or fair value is expressedmarketping.in
